CTMX CytomX
- 1.750
- 0.0000.00%
- 1.740
- -0.010-0.55%
CytomX News
CytomX | 8-K: Current report
CytomX | 8-K: Current report
CytomX | 8-K: CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
CytomX | DEFA14A: Others
CytomX | DEFA14A: Others
CytomX | DEF 14A: Definitive information statements
CytomX | PRE 14A: Preliminary proxy statements relating to merger or acquisition
CytomX | 8-K: Current report
CytomX | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
CytomX | 8-K: Current report
CytomX | 8-K: CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
CytomX | 8-K: Current report
CytomX | S-3: Registration statement for specified transactions by certain issuers
CytomX | 8-K: CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
CytomX | 8-K: Current report
CytomX | 8-K: Current report
CytomX | 8-K: CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
CytomX | DEFA14A: Others
CytomX | DEF 14A: Definitive proxy statements
CytomX | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
